Results 181 to 190 of about 1,230 (212)

Placebo Effect in Levodopa‐Induced Dyskinesia: A Systematic Review and Meta‐Analysis

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Levodopa‐induced dyskinesia (LID) is a complication of Parkinson's disease (PD) treatment. While the placebo effect is a known component in PD clinical trials, its specific magnitude in the context of LID is not well characterized.
Luiz Vinicius Silva Correa, Alexandre Martins do Nascimento, Bruno Lopes Santos‐Lobato, Henry Mauricio Chaparro‐Solano, Ignacio Fernandez Mata, Vitor Tumas   +5 more
wiley   +1 more source

Utility of Pelvic Floor Therapy and Behavioral Interventions in the Neurogenic Lower Urinary Tract Dysfunction (NLUTD) Population

Neurourology and Urodynamics, EarlyView.
ABSTRACT Aims Neurogenic lower urinary tract dysfunction (NLUTD) describes a wide range of symptoms depending on neurologic diagnosis and the resulting bladder and sphincter dysfunction. This narrative review is designed to address the question regarding which NLUTD population benefits most from pelvic floor therapy and behavioral interventions, and ...
Sara M. Lenherr
wiley   +1 more source

Pre‐Existing Nocturia Status Predicts Bladder Symptom Exacerbation Following COVID‐19 Vaccination in Women

The Kaohsiung Journal of Medical Sciences, EarlyView.
Hsien‐Che Ou, Hao‐Wei Chen, Yung‐Shun Juan, Yu‐Chen Chen   +3 more
wiley   +1 more source

Factors Underlying Choice and Change of Absorbent Incontinence Products in Women With Urinary Incontinence

Neurourology and Urodynamics, EarlyView.
ABSTRACT Background and Objective Urinary incontinence (UI) is common in women. For up to 77%, the use of absorbent continence products (pads) is central to management. Pad changes are common and reasons for change are not fully described. We hypothesized that women change their pads for many reasons other than wetness and at saturation levels well ...
Sarah Qureshi, Saima Rajabali, Adrian Wagg   +2 more
wiley   +1 more source

One‐Year Functional Satisfaction and Quality of Life Outcomes of Patients With a History of Radiotherapy With Artificial Urinary Sphincters

Neurourology and Urodynamics, EarlyView.
ABSTRACT Aims This study assessed how functional satisfaction and quality of life outcomes of the artificial urinary sphincter (AUS) were affected in patients who received radiation for prostate cancer. Methods A secondary analysis was conducted based on the Artificial Urinary Sphincter Clinical Outcomes (AUSCO) study, a prospective multi‐institutional
Vishu Chandrasekhar, Melissa R. Kaufman, Andrew C. Peterson, Erin L. Chaussee, Hadley M. Wood, AUSCO Collaboration Group, Benjamin N. Breyer, Bradley A. Erickson, Niels V. Johnsen, Jeremy Myers, Alex J. Vanni, Ryan Terlecki, Thomas G. Smith III, Daniel Moon Fracs, LeRoy Jones, Joshua A. Broghammer, Gerard Henry, Arthur L. Burnett, Lewis Wen Loong Chan, Brian J. Flynn, Rose Khavari, Sean Elliott   +21 more
wiley   +1 more source

Mirabegron and Intradetrusor Onabotulinumtoxina for Overactive Bladder in Parkinson's Disease: A Systematic Review and Meta‐Analysis

Neurourology and Urodynamics, EarlyView.
ABSTRACT Objective To synthesize the evidence on the efficacy and safety of mirabegron and intradetrusor onabotulinumtoxinA (BoNT‐A) as separate interventions for overactive bladder (OAB) in Parkinson's disease (PD). Methods A systematic review and meta‐analysis with parallel synthesis of two distinct interventions was conducted of randomized and ...
Hussain Arshad, Raiyana Nuha, Shehab Khashaba, David Gillatt, Simon J. G. Lewis   +4 more
wiley   +1 more source

Age and Nocturnal Polyuria in Nocturia: A Multicenter Voiding Diary Cohort Study

Neurourology and Urodynamics, EarlyView.
ABSTRACT Introduction Although the prevalence of nocturnal polyuria (NP) increases with age, the mechanisms underlying age‐related changes in voiding patterns and the daytime–nighttime distribution of urine volume remain unclear. Given that the severity of nocturia and bladder function may differ across age groups, age‐specific voiding profiles require
Kota Kawase, Yoshinori Nishino, Kanako Matsuoka, Shunta Makabe, Ryo Tanji, Hiroki Hoshino, Kei Kawada, Kousei Miwa, Masayuki Tomioka, Tomoki Taniguchi, Koji Iinuma, Yuki Tobisawa, Keita Nakane, Yoshiyuki Kojima, Takahiko Mitsui, Takuya Koie   +15 more
wiley   +1 more source

Prior Authorization for Sacral Nerve Stimulation in the Era of WISeR: Evaluation of U.S. Payer Coverage Policies

Neurourology and Urodynamics, EarlyView.
ABSTRACT Introduction Sacral nerve stimulation (SNS) is an established therapy for refractory urinary incontinence, yet the 2025 Wasteful and Inappropriate Service Reduction Model (WISeR) designated it as requiring mandatory prior authorization. No analysis has examined how U.S.
Thriaksh Rajan, Andre Revnew, David Sheyn, Adonis Hijaz, Ramy Abou Ghayda   +4 more
wiley   +1 more source